Compare THR & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | THR | NVAX |
|---|---|---|
| Founded | 1954 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.6B |
| IPO Year | 2011 | 1996 |
| Metric | THR | NVAX |
|---|---|---|
| Price | $60.36 | $7.94 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 9 |
| Target Price | ★ $54.00 | $11.33 |
| AVG Volume (30 Days) | 251.5K | ★ 3.0M |
| Earning Date | 05-21-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 3.97 | ★ 309.76 |
| EPS | 1.27 | ★ 2.58 |
| Revenue | $276,181,000.00 | ★ $1,123,479,000.00 |
| Revenue This Year | $6.08 | N/A |
| Revenue Next Year | $5.95 | N/A |
| P/E Ratio | $42.81 | ★ $3.12 |
| Revenue Growth | N/A | ★ 64.69 |
| 52 Week Low | $23.86 | $5.80 |
| 52 Week High | $58.56 | $11.85 |
| Indicator | THR | NVAX |
|---|---|---|
| Relative Strength Index (RSI) | 72.02 | 38.31 |
| Support Level | $24.85 | $7.81 |
| Resistance Level | N/A | $8.45 |
| Average True Range (ATR) | 2.09 | 0.33 |
| MACD | 0.32 | -0.01 |
| Stochastic Oscillator | 99.26 | 8.00 |
Thermon Group Holdings Inc is a United States-based company that provides engineered industrial process heating solutions for process industries. It offers a full suite of products (heating units, electrode and gas-fired boilers, heating cables, industrial heating blankets and related products, temporary power solutions and tubing bundles), services (engineering, installation and maintenance services) and software (design optimization and wireless and network control systems) required to deliver comprehensive solutions to some of the world's Large and most complex projects. Its products and services include a wide range of electric heat tracing cables, steam heating solutions, controls, monitoring and software, instrumentation, project services, industrial heating and filtration solutions.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.